Showing results (131-140 of 139) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Neuro-Oncology|May 13, 2017
Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPNJohn-Paul Kilday, Massimo Caldarelli, Luca Massimi, et al.European Journal of Cancer (Oxford, England : 1990)|April 20, 2020
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatmentOndrej Hrusak, Tomas Kalina, Joshua Wolf, et al.Blood|November 4, 2022
EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapySarah Elitzur, Ajay Vora, Birgit Burkhardt, et al.Blood|June 25, 2024
ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignanciesSarah Elitzur, Ruth Shiloh, Jan L C Loeffen, et al.The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very youngShunsuke Kimura, Petri Polonen, Lindsey Montefiori, et al.Blood Advances|February 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patientsJean Donadieu, Dmitry Evseev, Francesco Pegoraro, et al.Blood|April 7, 2025
Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemiaSara K Silbert, Alexander W Rankin, Chloe N Hoang, et al.Cancer Discovery|June 25, 2024
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High RiskShunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, et al.Pageof 14